Device/Diagnostics Quarterly Dealmaking Statistics, Q3 2018
A look at the financing, M&A and alliance activity in July–September 2018
Executive Summary
Third quarter device financing totaled $2.6 billion, a 24% decrease from the $3.4 billion brought in during Q2. The change partially stems from a sharp decline in debt financing. During the third quarter, debt raises brought in $258 million, just 10% of the Q3 total, while in the previous quarter, aggregate debt (at $947 million) represented 28% of the financing total.